Serum p53 Autoantibodies in the Follow-Up of Head and Neck Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|59|1|31-35

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.1, 2000-06, pp. : 31-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Follow-Up with Serum Cyfra 21-1 in Patients with Squamous Cell Carcinomas of the Head and Neck

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 280-285

Karger

Access to resources Recommend Favorite

A national survey of healthcare professionals' views on models of follow‐up, holistic needs assessment and survivorship care for patients with head and neck cancer

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 6, 2015-11 ,pp. : 873-883

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnostic Value of 123I-IMT SPECT in the Follow-up of Head and Neck Cancer

By  

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 147-152

Karger

Access to resources Recommend Favorite

Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long‐term follow‐up of a large series

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 10, 2015-10 ,pp. : 1403-1409

John Wiley & Sons Inc

Access to resources Recommend Favorite

Importance of Serum p53 Antibodies during Follow-Up after Treatment of Invasive Bladder Tumors

By  

Urologia Internationalis, Vol. 72, Iss. 4, 2004-05 ,pp. : 292-298

Karger

Access to resources Recommend Favorite